Guggenheim Active Allocation Fund
Sponsor: Guggenheim · Inception Nov 24, 2021 · Pays monthly
Market priceShare price
$13.69
-0.58% ($-0.08)
NAVAsset value per share
$15.90
as of Oct 14, 2026 · Nasdaq NAV symbol
Premium / discountPrice vs. assets
13.90% discount *
Indicative: latest price vs latest reported NAV
Distribution rate (price)Payout rate
10.41%
regular, annualised · on NAV 8.96%
Expense ratioAnnual cost
Not reported
no tagged fee table
LeverageBorrowing
Not reported
senior securities not tagged
Quote status: Market closed — last regular-session price · last trade Oct 16, 2026, 4:00 PM EDT (exchange time, ET) · retrieved Oct 16, 2026, 10:40 PM EDTRegular-session prices; extended-hours quotes are not displayed.
Full portfolio as filed on SEC Form N-PORT for the month ending May 29, 2026, filed Jul 22, 2026. 1,258 positions; weights are percent of net assets as reported. Weights sum to 100.0% — leverage, cash, derivatives and short positions mean totals need not equal 100%. This is a historical report, not a live portfolio.
Asset class
| Asset class | % net assets | Value |
|---|---|---|
| CDO/CLO | 7.20% | $45.5M |
| ABS (other) | 6.53% | $41.2M |
| Debt | 58.82% | $371M |
| Equity (common) | 4.33% | $27.3M |
| Loans | 30.86% | $195M |
| Derivative (equity) | 2.01% | $12.7M |
| Mortgage-backed | 12.91% | $81.5M |
| Short-term investment vehicle | 1.96% | $12.4M |
| Equity (preferred) | 1.69% | $10.7M |
| Derivative (FX) | 0.10% | $656K |
| Repurchase agreement | -26.02% | $-164M |
| Derivative (interest rate) | -0.26% | $-1.6M |
| Derivative (credit) | -0.13% | $-840K |
| Derivative (commodity) | -0.00% | $-3.2K |
Country (top 12)
| Country (top 12) | % net assets | Value |
|---|---|---|
| United States | 67.63% | $427M |
| United Kingdom | 6.08% | $38.4M |
| Canada | 5.81% | $36.6M |
| Cayman Islands | 4.37% | $27.6M |
| Luxembourg | 2.77% | $17.5M |
| France | 2.50% | $15.8M |
| Netherlands | 2.48% | $15.6M |
| Germany | 1.50% | $9.5M |
| Australia | 1.18% | $7.5M |
| Jersey | 1.13% | $7.1M |
| Spain | 0.92% | $5.8M |
| Italy | 0.72% | $4.5M |
Region
| Region | % net assets | Value |
|---|---|---|
| United States | 67.63% | $427M |
| Canada | 5.81% | $36.6M |
| Offshore domiciles | 4.89% | $30.9M |
| Developed Europe | 20.17% | $127M |
| Australia & New Zealand | 1.18% | $7.5M |
| Latin America | 0.21% | $1.3M |
| Other | 0.11% | $712K |
| Middle East | 0.00% | $249 |
Issuer type
| Issuer type | % net assets | Value |
|---|---|---|
| Corporate | 80.43% | $508M |
| Registered fund | 3.05% | $19.3M |
| U.S. Treasury | 2.62% | $16.5M |
| U.S. GSE | 12.59% | $79.4M |
| Non-U.S. sovereign | 1.31% | $8.3M |
Fair-value level
| Fair-value level | % net assets | Value |
|---|---|---|
| Level 1 | 8.15% | $51.4M |
| Level 2 | 77.53% | $489M |
| Level 3 | 14.32% | $90.4M |
Level 3 = valued with unobservable inputs (typically private or illiquid).
Long / short
| Long / short | % net assets | Value |
|---|---|---|
| Long | 124.30% | $785M |
| N/A | 1.72% | $10.9M |
| Short | -26.02% | $-164M |
All allocation percentages use net assets as the denominator (N-PORT convention). A position's share of invested assets may differ from its share of the whole fund including cash and leverage.
| Security | Identifier | Type | Issuer | Country | Balance | Units | Value (USD) | Weight | FV level |
|---|---|---|---|---|---|---|---|---|---|
| WEREWOLF THERAPEUTICS INC | 95075A107 | Equity | CORP | United States | 153 | shares | $69 | 0.00% | 1 |
| PASSAGE BIO INC | 702712209 | Equity | CORP | United States | 11 | shares | $63 | 0.00% | 1 |
| YELLOW CORP | 985510106 | Equity | CORP | United States | 300 | shares | $63 | 0.00% | 2 |
| PRECISION BIOSCIENCES INC | 74019P207 | Equity | CORP | United States | 9 | shares | $63 | 0.00% | 1 |
| BIODESIX INC | 09075X207 | Equity | CORP | United States | 3 | shares | $49 | 0.00% | 1 |
| HYDROFARM HOLDINGS GROUP INC | 44888K407 | Equity | CORP | United States | 46 | shares | $45 | 0.00% | 1 |
| KORRO BIO INC | 500946108 | Equity | CORP | United States | 3 | shares | $40 | 0.00% | 1 |
| LUCID DIAGNOSTICS INC | 54948X109 | Equity | CORP | United States | 39 | shares | $40 | 0.00% | 1 |
| FIRST REPUBLIC BANK | 33616C696 | Preferred | CORP | United States | 200,000 | shares | $40 | 0.00% | 2 |
| FORTE BIOSCIENCES INC | 34962G208 | Equity | CORP | United States | 2 | shares | $38 | 0.00% | 1 |
| A.K.A. BRANDS HOLDING CORP | 00152K200 | Equity | CORP | United States | 4 | shares | $38 | 0.00% | 1 |
| KALARIS THERAPEUTICS INC | 482929106 | Equity | CORP | United States | 7 | shares | $37 | 0.00% | 1 |
| LITE STRATEGY INC | 55279B301 | Equity | CORP | United States | 33 | shares | $33 | 0.00% | 1 |
| PERSHING SQUARE TONTINE HOLDINGS LTD | 715ESC018 | Equity | CORP | United States | 329,700 | shares | $33 | 0.00% | 3 |
| BOLT BIOTHERAPEUTICS INC | 097702203 | Equity | CORP | United States | 6 | shares | $32 | 0.00% | 1 |
| ASHFORD HOSPITALITY TRUST INC | 044103794 | Equity | CORP | United States | 10 | shares | $31 | 0.00% | 1 |
| SMITH MICRO SOFTWARE INC | 832154405 | Equity | CORP | United States | 34 | shares | $30 | 0.00% | 1 |
| ALIGOS THERAPEUTICS INC | 01626L204 | Equity | CORP | United States | 5 | shares | $29 | 0.00% | 1 |
| INOTIV INC | 45783Q100 | Equity | CORP | United States | 99 | shares | $28 | 0.00% | 1 |
| BED BATH & BEYOND INCrestricted | 075896159 | Equity deriv. | CORP | United States | 50 | contracts | $28 | 0.00% | 1 |
| XILIO THERAPEUTICS INC | 98422T209 | Equity | CORP | United States | 3 | shares | $25 | 0.00% | 1 |
| VISTAGEN THERAPEUTICS INC | 92840H400 | Equity | CORP | United States | 38 | shares | $24 | 0.00% | 1 |
| TVARDI THERAPEUTICS INC | 140755307 | Equity | CORP | United States | 7 | shares | $24 | 0.00% | 1 |
| UBS AG | — | Equity deriv. | CORP | Switzerland | 1 | contracts | $21 | 0.00% | 2 |
| CAMBIUM NETWORKS CORP | KYG177661090 | Equity | CORP | Cayman Islands | 63 | shares | $21 | 0.00% | 1 |
| BARNES & NOBLE EDUCATION INC | 06777U200 | Equity | CORP | United States | 2 | shares | $21 | 0.00% | 1 |
| FATHOM HOLDINGS INC | 31189V109 | Equity | CORP | United States | 36 | shares | $21 | 0.00% | 1 |
| AQUABOUNTY TECHNOLOGIES INC | 03842K309 | Equity | CORP | United States | 17 | shares | $18 | 0.00% | 1 |
| AVALO THERAPEUTICS INC | 05338F306 | Equity | CORP | United States | 1 | shares | $16 | 0.00% | 1 |
| ASPIRA WOMEN'S HEALTH INC | 04537Y208 | Equity | CORP | United States | 28 | shares | $15 | 0.00% | 1 |
| CURIS INC | 231269309 | Equity | CORP | United States | 25 | shares | $14 | 0.00% | 1 |
| Endo GUC Trust Units Cl A-1 | — | Equity | CORP | United States | 133,456 | shares | $13 | 0.00% | 3 |
| ATERIAN INC | 02156U200 | Equity | CORP | United States | 12 | shares | $13 | 0.00% | 1 |
| QUINCE THERAPEUTICS INC | 22053A206 | Equity | CORP | United States | 11 | shares | $13 | 0.00% | 1 |
| HOOKIPA PHARMA INC | 43906K209 | Equity | CORP | United States | 11 | shares | $13 | 0.00% | 1 |
| PERSHING SQUARE SPARC HOLDINGS LTD | 714920113 | Equity | CORP | United States | 82,425 | shares | $8 | 0.00% | 3 |
| FINCH THERAPEUTICS GROUP INC | 31773D200 | Equity | CORP | United States | 1 | shares | $7 | 0.00% | 2 |
| PAVMED INC | 70387R502 | Equity | CORP | United States | 1 | shares | $6 | 0.00% | 1 |
| SOLO BRANDS INC | 83425V203 | Equity | CORP | United States | 1 | shares | $4 | 0.00% | 1 |
| BIOATLA INC | 09077B203 | Equity | CORP | United States | 1 | shares | $4 | 0.00% | 1 |
| WORKHORSE GROUP INC | 98138J503 | Equity | CORP | United States | 1 | shares | $4 | 0.00% | 1 |
| IBIO INC | 451033708 | Equity | CORP | United States | 2 | shares | $4 | 0.00% | 1 |
| SQZ BIOTECHNOLOGIES COMPANY | 78472W104 | Equity | CORP | United States | 135 | shares | $3 | 0.00% | 2 |
| FIRST REPUBLIC BANK | 33616C100 | Equity | CORP | United States | 1,594 | shares | $3 | 0.00% | 1 |
| SORRENTO THERAPEUTICS INC | 83587F202 | Equity | CORP | United States | 3,481 | shares | $2 | 0.00% | 1 |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | Equity | CORP | United Kingdom | 273 | shares | $2 | 0.00% | 1 |
| GT BIOPHARMA INC | 36254L308 | Equity | CORP | United States | 3 | shares | $1 | 0.00% | 1 |
| ALPHA COMPUTE CORP | VGG7185A1369 | Equity | CORP | British Virgin Islands | 2 | shares | $1 | 0.00% | 1 |
| OFFICE PROPERTIES INCOME TRUST | 67623C109 | Equity | CORP | United States | 281 | shares | $1 | 0.00% | 1 |
| 22ND CENTURY GROUP INC | 90137F608 | Equity | CORP | United States | 1 | shares | $1 | 0.00% | 1 |
| HPC NAV I 2025 UNFUNDED | — | Debt | CORP | United States | 4,314,560 | principal | $0 | 0.00% | 3 |
| BIG LOTS INC | 089302103 | Equity | CORP | United States | 354 | shares | $0 | 0.00% | 2 |
| FISKER INC | 33813J106 | Equity | CORP | United States | 1,915 | shares | $0 | 0.00% | 3 |
| TELESIS BIO INC | 192003200 | Equity | CORP | United States | 3 | shares | $0 | 0.00% | 1 |
| CONTRA CVR SESEN BIO | — | Equity | CORP | United States | 1,182 | shares | $0 | 0.00% | 3 |
| ASSERTIO HLDGS INC USD - CVR | — | Equity | CORP | United States | 971 | shares | $0 | 0.00% | 3 |
| SOCIETY PASS INC | 83370P201 | Equity | CORP | United States | 2 | shares | $0 | 0.00% | 1 |
| EPIZYME CONTINGENT VALUE RIGHTS | — | Equity | CORP | United States | 793 | shares | $0 | 0.00% | 3 |
| ESC NANOSTRING TECHNOL + NPV | — | Equity | CORP | United States | 532 | shares | $0 | 0.00% | 3 |
| CARTESIAN THERAPEUTICS INC | — | Equity | CORP | United States | 542 | shares | $0 | 0.00% | 3 |
| VINCERX PHARMA INC | 92731L304 | Equity | CORP | United States | 4 | shares | $0 | 0.00% | 1 |
| RUBIUS THERAPEUTICS INC | 78116T103 | Equity | CORP | United States | 547 | shares | $0 | 0.00% | 3 |
| HUMANIGEN INC | 444863203 | Equity | CORP | United States | 284 | shares | $0 | 0.00% | 3 |
| HOMOLOGY MEDICINES INC | — | Equity | CORP | United States | 249 | shares | $0 | 0.00% | 3 |
| GURNET POINT CAPITAL LLC-CVR | — | Equity | CORP | United States | 285 | shares | $0 | 0.00% | 3 |
| FREQUENCY THERAPEUTICS INC | — | Equity | CORP | United States | 191 | shares | $0 | 0.00% | 3 |
| MAGENTA THERAPEUTICS INC - CVR | — | Equity | CORP | United States | 178 | shares | $0 | 0.00% | 3 |
| CONTRA ATRECA INC | — | Equity | CORP | United States | 154 | shares | $0 | 0.00% | 3 |
| LL FLOORING HOLDINGS INC | 55003T107 | Equity | CORP | United States | 170 | shares | $0 | 0.00% | 3 |
| XOMA CORP - CVR | — | Equity | CORP | United States | 153 | shares | $0 | 0.00% | 3 |
| SURFACE ONCOLOGY INC CVR | — | Equity | CORP | United States | 208 | shares | $0 | 0.00% | 3 |
| IKENA ONCOLOGY INC - CVR | — | Equity | CORP | United States | 161 | shares | $0 | 0.00% | 3 |
| SPYRE THERAPEUTICS INC CVR | — | Equity | CORP | United States | 240 | shares | $0 | 0.00% | 3 |
| CONCENTRA BIOSCIENCESLLC- | — | Equity | CORP | United States | 231 | shares | $0 | 0.00% | 3 |
| SYROS PHARMACEUTICALS INC | 87184Q206 | Equity | CORP | United States | 34 | shares | $0 | 0.00% | 1 |
| GENERATION BIO CO | ticker GBIO | Equity | CORP | United States | 52 | shares | $0 | 0.00% | 3 |
| CARISMA THERAPEUTICS INC | 14216R101 | Equity | CORP | United States | 59 | shares | $0 | 0.00% | 1 |
| CONTRA LIGAND PHARMACE- NPV | 532CNT011 | Equity | CORP | United States | 67 | shares | $0 | 0.00% | 3 |
| BAUSCH HEALTH COS INC-CVR | — | Equity deriv. | CORP | United States | 134 | contracts | $0 | 0.00% | 3 |
| CONN'S INC | 208242107 | Equity | CORP | United States | 106 | shares | $0 | 0.00% | 3 |
| SHIFT TECHNOLOGIES INC | 82452T305 | Equity | CORP | United States | 102 | shares | $0 | 0.00% | 3 |
| CURO GROUP HOLDINGS CORP | — | Equity | CORP | United States | 125 | shares | $0 | 0.00% | 3 |
| CONTRA LIGAND PHARMACE- NPV | 532CNT029 | Equity | CORP | United States | 67 | shares | $0 | 0.00% | 3 |
| AFFIMED NV | NL0015001ZQ0 | Equity | CORP | Netherlands | 69 | shares | $0 | 0.00% | 2 |
| APPLIED THERAPEUTICS INC | ticker APLT | Equity | CORP | United States | 105 | shares | $0 | 0.00% | 3 |
| CODIAK BIOSCIENCES INC | 192010106 | Equity | CORP | United States | 94 | shares | $0 | 0.00% | 3 |
| CYTEIR THERAPEUTICS INC | — | Equity | CORP | United States | 99 | shares | $0 | 0.00% | 3 |
| ACUTUS MEDICAL INC | 005111109 | Equity | CORP | United States | 113 | shares | $0 | 0.00% | 1 |
| VIEWRAY INC | 92672L107 | Equity | CORP | United States | 837 | shares | $0 | 0.00% | 2 |
| META MATERIALS INC | 59134N302 | Equity | CORP | United States | 12 | shares | $0 | 0.00% | 1 |
| CANOO INC | 13803R300 | Equity | CORP | United States | 2 | shares | $0 | 0.00% | 1 |
| EBET INC | 278700208 | Equity | CORP | United States | 3 | shares | $0 | 0.00% | 1 |
| IDEANOMICS INC | 45166V205 | Equity | CORP | United States | 22 | shares | $0 | 0.00% | 3 |
| TREVENA INC | 89532E307 | Equity | CORP | United States | 1 | shares | $0 | 0.00% | 1 |
| KEZAR LIFE SCIENCES INC | ticker KZR | Equity | CORP | United States | 21 | shares | $0 | 0.00% | 3 |
| NEOLEUKIN THERAPEUTICS INC | — | Equity | CORP | United States | 41 | shares | $0 | 0.00% | 3 |
| ARCIMOTO INC | 039587209 | Equity | CORP | United States | 9 | shares | $0 | 0.00% | 1 |
| ONTRAK INC | 683373401 | Equity | CORP | United States | 1 | shares | $0 | 0.00% | 2 |
| CARLYLE FINANCE LLC | — | Equity | CORP | United States | 20 | shares | $0 | 0.00% | 3 |
| AKOUSTIS TECHNOLOGIES INC | 00973N102 | Equity | CORP | United States | 287 | shares | $0 | 0.00% | 3 |
| ONCTERNAL THERAPEUTICS INC | 68236P206 | Equity | CORP | United States | 13 | shares | $0 | 0.00% | 3 |
| CONCENTRA BIOSCIENCES LLC | — | Equity | CORP | United States | 48 | shares | $0 | 0.00% | 3 |
| HYRECAR INC | 44916T107 | Equity | CORP | United States | 104 | shares | $0 | 0.00% | 1 |
| ATHERSYS INC | 04744L205 | Equity | CORP | United States | 49 | shares | $0 | 0.00% | 2 |
| CUE HEALTH INC | 229790100 | Equity | CORP | United States | 85 | shares | $0 | 0.00% | 2 |
| ABBVIE INC-CVR | — | Equity | CORP | United States | 2 | shares | $0 | 0.00% | 3 |
| INFINITY PHARMACEUTICALS INC | 45665G303 | Equity | CORP | United States | 521 | shares | $0 | 0.00% | 2 |
| AVROBIO INC | ticker AVRO | Equity | CORP | United States | 18 | shares | $0 | 0.00% | 3 |
| ELI LILLY & CO-CVR | — | Equity | CORP | United States | 6 | shares | $0 | 0.00% | 3 |
| 9 METERS BIOPHARMA INC | 654405208 | Equity | CORP | United States | 67 | shares | $0 | 0.00% | 1 |
| AUDACY INC | 05070N202 | Equity | CORP | United States | 23 | shares | $0 | 0.00% | 3 |
| MORGAN STANLEY & CO. INTERNATIONAL PLC | — | Equity deriv. | CORP | United Kingdom | 2 | contracts | $-0 | 0.00% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -4,751,500 | principal | $-4.8M | -0.75% | 2 |
| BANK OF AMERICA MERRILL LYNCH BANCO MULTIPLO S.A.short | — | Repo | CORP | United States | -4,343,750 | principal | $-4.3M | -0.69% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -4,175,381 | principal | $-4.2M | -0.66% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -3,915,313 | principal | $-3.9M | -0.62% | 2 |
| CITIGROUP GLOBAL MARKETS INC.short | — | Repo | CORP | United States | -3,569,125 | principal | $-3.6M | -0.57% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -3,492,188 | principal | $-3.5M | -0.55% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -3,419,475 | principal | $-3.4M | -0.54% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -3,386,750 | principal | $-3.4M | -0.54% | 2 |
| TD SECURITIES (USA) LLCshort | — | Repo | CORP | United States | -3,349,001 | principal | $-3.3M | -0.53% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -3,330,103 | principal | $-3.3M | -0.53% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -2,868,495 | principal | $-2.9M | -0.45% | 2 |
| CITIGROUP GLOBAL MARKETS INC.short | — | Repo | CORP | United States | -2,849,054 | principal | $-2.8M | -0.45% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -2,784,375 | principal | $-2.8M | -0.44% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -2,740,348 | principal | $-2.7M | -0.43% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -2,710,125 | principal | $-2.7M | -0.43% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -2,672,389 | principal | $-2.7M | -0.42% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -2,653,560 | principal | $-2.7M | -0.42% | 2 |
| BANK OF AMERICA MERRILL LYNCH BANCO MULTIPLO S.A.short | — | Repo | CORP | United States | -2,602,500 | principal | $-2.6M | -0.41% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -2,565,938 | principal | $-2.6M | -0.41% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -2,539,063 | principal | $-2.5M | -0.40% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -2,416,500 | principal | $-2.4M | -0.38% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -2,404,684 | principal | $-2.4M | -0.38% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -2,370,125 | principal | $-2.4M | -0.38% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -2,355,188 | principal | $-2.4M | -0.37% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -2,323,625 | principal | $-2.3M | -0.37% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -2,070,000 | principal | $-2.1M | -0.33% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,977,250 | principal | $-2M | -0.31% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,850,750 | principal | $-1.9M | -0.29% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,822,080 | principal | $-1.8M | -0.29% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,811,063 | principal | $-1.8M | -0.29% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,693,375 | principal | $-1.7M | -0.27% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -1,641,875 | principal | $-1.6M | -0.26% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,610,813 | principal | $-1.6M | -0.26% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,606,500 | principal | $-1.6M | -0.25% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,544,358 | principal | $-1.5M | -0.24% | 2 |
| CHICAGO MERCANTILE EXCHANGE INC. | — | Rate deriv. | CORP | United States | 3 | contracts | $-1.5M | -0.24% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,517,215 | principal | $-1.5M | -0.24% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,509,375 | principal | $-1.5M | -0.24% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,452,000 | principal | $-1.5M | -0.23% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -1,450,313 | principal | $-1.5M | -0.23% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,435,735 | principal | $-1.4M | -0.23% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -1,434,375 | principal | $-1.4M | -0.23% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,426,000 | principal | $-1.4M | -0.23% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -1,416,938 | principal | $-1.4M | -0.22% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,385,351 | principal | $-1.4M | -0.22% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,382,063 | principal | $-1.4M | -0.22% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -1,353,338 | principal | $-1.4M | -0.21% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,304,390 | principal | $-1.3M | -0.21% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,294,313 | principal | $-1.3M | -0.21% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,283,500 | principal | $-1.3M | -0.20% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,275,472 | principal | $-1.3M | -0.20% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,274,063 | principal | $-1.3M | -0.20% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,270,283 | principal | $-1.3M | -0.20% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,263,700 | principal | $-1.3M | -0.20% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,255,088 | principal | $-1.3M | -0.20% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,250,438 | principal | $-1.3M | -0.20% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,245,633 | principal | $-1.2M | -0.20% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,236,790 | principal | $-1.2M | -0.20% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,234,020 | principal | $-1.2M | -0.20% | 2 |
| J.P. MORGAN SECURITIES LLCshort | — | Repo | CORP | United States | -1,233,911 | principal | $-1.2M | -0.20% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,214,171 | principal | $-1.2M | -0.19% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,191,128 | principal | $-1.2M | -0.19% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,187,953 | principal | $-1.2M | -0.19% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,185,938 | principal | $-1.2M | -0.19% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,183,753 | principal | $-1.2M | -0.19% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -1,142,785 | principal | $-1.1M | -0.18% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,139,520 | principal | $-1.1M | -0.18% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -1,080,750 | principal | $-1.1M | -0.17% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -994,375 | principal | $-994K | -0.16% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -974,000 | principal | $-974K | -0.15% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -922,688 | principal | $-923K | -0.15% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -922,500 | principal | $-923K | -0.15% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -892,125 | principal | $-892K | -0.14% | 2 |
| BANK OF AMERICA MERRILL LYNCH BANCO MULTIPLO S.A.short | — | Repo | CORP | United States | -876,375 | principal | $-876K | -0.14% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -863,096 | principal | $-863K | -0.14% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -841,500 | principal | $-842K | -0.13% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -815,456 | principal | $-815K | -0.13% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -794,599 | principal | $-795K | -0.13% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -777,750 | principal | $-778K | -0.12% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -768,000 | principal | $-768K | -0.12% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -765,000 | principal | $-765K | -0.12% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -758,625 | principal | $-759K | -0.12% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -748,863 | principal | $-749K | -0.12% | 2 |
| BANK OF AMERICA MERRILL LYNCH BANCO MULTIPLO S.A.short | — | Repo | CORP | United States | -748,800 | principal | $-749K | -0.12% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -745,042 | principal | $-745K | -0.12% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -743,438 | principal | $-743K | -0.12% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -742,875 | principal | $-743K | -0.12% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -739,000 | principal | $-739K | -0.12% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -736,000 | principal | $-736K | -0.12% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -716,571 | principal | $-717K | -0.11% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -709,688 | principal | $-710K | -0.11% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -682,335 | principal | $-682K | -0.11% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -671,430 | principal | $-671K | -0.11% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -626,964 | principal | $-627K | -0.10% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -551,375 | principal | $-551K | -0.09% | 2 |
| INTERCONTINENTAL EXCHANGE, INC. | — | Credit deriv. | CORP | United States | 1 | contracts | $-548K | -0.09% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -506,081 | principal | $-506K | -0.08% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -488,014 | principal | $-488K | -0.08% | 2 |
| BANK OF AMERICA MERRILL LYNCH BANCO MULTIPLO S.A.short | — | Repo | CORP | United States | -465,000 | principal | $-465K | -0.07% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -456,000 | principal | $-456K | -0.07% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -445,004 | principal | $-445K | -0.07% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -444,393 | principal | $-444K | -0.07% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -441,112 | principal | $-441K | -0.07% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -435,365 | principal | $-435K | -0.07% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -360,469 | principal | $-360K | -0.06% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -349,219 | principal | $-349K | -0.06% | 2 |
| BANK OF AMERICA MERRILL LYNCH BANCO MULTIPLO S.A.short | — | Repo | CORP | United States | -335,563 | principal | $-336K | -0.05% | 2 |
| J.P. MORGAN SECURITIES LLCshort | — | Repo | CORP | United States | -332,500 | principal | $-333K | -0.05% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -327,931 | principal | $-328K | -0.05% | 2 |
| NATIXIS NORTH AMERICA LLCshort | — | Repo | CORP | United States | -318,553 | principal | $-319K | -0.05% | 2 |
| BANK OF AMERICA CORPORATIONshort | — | Repo | CORP | United States | -292,031 | principal | $-292K | -0.05% | 2 |
| TD SECURITIES (USA) LLCshort | — | Repo | CORP | United States | -262,625 | principal | $-263K | -0.04% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -253,630 | principal | $-254K | -0.04% | 2 |
| INTERCONTINENTAL EXCHANGE, INC. | — | Credit deriv. | CORP | United States | 1 | contracts | $-246K | -0.04% | 2 |
| SOCIETE GENERALEshort | — | Repo | CORP | United States | -242,104 | principal | $-242K | -0.04% | 2 |
| CHICAGO MERCANTILE EXCHANGE | ticker SR3 Z27-CME | Rate deriv. | CORP | United States | 115 | contracts | $-234K | -0.04% | 1 |
| TD SECURITIES (USA) LLCshort | — | Repo | CORP | United States | -195,750 | principal | $-196K | -0.03% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260603C0736 | Equity deriv. | CORP | United States | -7 | contracts | $-155K | -0.02% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260602C0738 | Equity deriv. | CORP | United States | -7 | contracts | $-144K | -0.02% | 2 |
| BANK OF AMERICA MERRILL LYNCH BANCO MULTIPLO S.A.short | — | Repo | CORP | United States | -126,481 | principal | $-126K | -0.02% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260604C0742 | Equity deriv. | CORP | United States | -7 | contracts | $-116K | -0.02% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260605C0744 | Equity deriv. | CORP | United States | -7 | contracts | $-109K | -0.02% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260601C0743 | Equity deriv. | CORP | United States | -7 | contracts | $-107K | -0.02% | 2 |
| BANK OF AMERICA MERRILL LYNCH BANCO MULTIPLO S.A.short | — | Repo | CORP | United States | -100,650 | principal | $-101K | -0.02% | 2 |
| NATIXISshort | — | Repo | CORP | United States | -95,906 | principal | $-95.9K | -0.02% | 2 |
| J.P. MORGAN SECURITIES LLCshort | — | Repo | CORP | United States | -90,000 | principal | $-90K | -0.01% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260608C0749 | Equity deriv. | CORP | United States | -7 | contracts | $-82.3K | -0.01% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260609C0750 | Equity deriv. | CORP | United States | -7 | contracts | $-76.6K | -0.01% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260610C0752 | Equity deriv. | CORP | United States | -7 | contracts | $-69.8K | -0.01% | 2 |
| BNP PARIBAS | — | Rate deriv. | CORP | France | -21,075,000 | contracts | $-68.4K | -0.01% | 2 |
| GOLDMAN SACHS & CO. LLC | — | Equity deriv. | CORP | United States | -253,962 | contracts | $-64.2K | -0.01% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260529C0750 | Equity deriv. | CORP | United States | -7 | contracts | $-61.1K | -0.01% | 2 |
| THE OPTIONS CLEARING CORPORATION | ticker SPXW 260611C0756 | Equity deriv. | CORP | United States | -7 | contracts | $-56.1K | -0.01% | 2 |
| BANK OF AMERICA, NATIONAL ASSOCIATION | — | Equity deriv. | CORP | United States | -85,129 | contracts | $-55.5K | -0.01% | 2 |
| INTERCONTINENTAL EXCHANGE, INC. | — | Credit deriv. | CORP | United States | 1 | contracts | $-45.9K | -0.01% | 2 |
| BARCLAYS BANK PLC | — | Rate deriv. | CORP | United Kingdom | -5,268,750 | contracts | $-45.3K | -0.01% | 2 |
| THE TORONTO-DOMINION BANK | — | Rate deriv. | CORP | Canada | -8,430,000 | contracts | $-39.6K | -0.01% | 2 |
| BANK OF AMERICA, NATIONAL ASSOCIATION | — | Equity deriv. | CORP | United States | 1 | contracts | $-24.5K | -0.00% | 2 |
Equities show share counts; bonds and loans show principal amount. Coupon, maturity and ratings are shown where the filing discloses them. Source: SEC N-PORT via market-data vendor re-serve, position-level.
Holdings reports on file
| Report date | Filed | Positions | Σ weight | Net assets (calc.) | Coverage |
|---|---|---|---|---|---|
| May 29, 2026 | Jul 22, 2026 | 1,258 | 100.0% | $631M | full |
| Feb 27, 2026 | Apr 29, 2026 | 1,236 | 100.0% | $638M | full |
| Nov 30, 2025 | Jan 28, 2026 | 1,148 | 100.0% | $580M | full |
Net assets here are calculated from position values ÷ reported weights (median across positions), not a reported figure.
CEF Explorer research page for Guggenheim Active Allocation Fund. Figures carry their own dates and sources; a discount to NAV does not guarantee convergence or any return. This is not investment advice.